Lessons from COVID-19: Impact on Healthcare Systems and Technology uncovers the impact that COVID-19 has made on healthcare and technology industries. State-of-the-art case studies, empirical research, and new trends in technology-mediated solution are discussed to help inform and guide readers in understanding the effects that the COVID-19 outbreak has had across healthcare and technology industries. The book discusses challenges to identify vaccines, changes in legislation on clinical trials and re-purposing of licensed drugs, effects on primary healthcare, best practices adopted by different countries to control the pandemic, and different effects on patients within diverse age groups and comorbidities. In addition, the book covers technology-mediated solutions and infrastructures applied, digital transformations, modeling techniques, statistical projections, and the benefits and use of cloud computing and artificial intelligence. This is a valuable resource for healthcare professionals, medical doctors, researchers and graduate students from both biomedical and technological fields who are interested in learning more about the use of new technologies to fight a pandemic. - Discusses the effects of COVID-19 on healthcare and technology - Presents case studies and state-of-the-art research and technologies to help readers effectively understand the effects of COVID-19 - Empowers researchers to work on effective hypothesis to test the disruptions and changes that have occurred as a result of COVID-19 - Bridges practical and theoretical gaps in terms of lessons learned during COVID-19 in the healthcare and technology sectors

Using the SARS-CoV-2/CoVID-19 pandemic as a giant case study, and following the structure of the domains of information security, this book looks at what the crisis teaches us about security. It points out specific security fundamentals where social, medical, or business responses to the crisis failed or needed to make specific use of those concepts. For the most part, these lessons are simply reminders of factors that get neglected during times of non-crisis. The lessons particularly point out the importance of planning and resilience in systems and business. Those studying cybersecurity and its preventive measures and applications, as well as those involved in risk management studies and assessments, will all benefit greatly from the book. Robert Slade has had an extensive and prolific career in management, security, and telecommunications research, analysis, and consultancy. He has served as an educator visiting universities and delivering lecturers and seminars.

The COVID-19 pandemic has shaken long-accepted beliefs about education, showing that learning can occur anywhere, at any time, and that education systems are not too heavy to move. When surveyed in May 2020, only around one-fifth of OECD education systems aimed to reinstate the status quo. Policy makers must therefore maintain the momentum of collective emergency action to drive education into a new and better normal.

COVID-19 Global Lessons Learned is a collection of 6 interactive case studies, 6-10-page each, that is designed for online or classroom discussion or as graded assignments. The case studies include links to websites and videos, discussion and interactive questions, plus a full package of instructor resources including a helpful instructor’s guide with sample answers to discussion questions, and a test bank. The 6 Interactive Case Studies include: 1. Clinical course of COVID-19 2. Epidemiology of COVID-19 3. Testing for COVID-19 4. Population Prevention and COVID-19 5. Treatment of COVID-19 6 Health Policy and Communications for COVID-19 Available at no additional cost (excluding Inclusive Access) when bundled with a Jones & Bartlett Learning text, these case studies are designed to be used in a wide range of courses.

The COVID-19 pandemic presented unique global health, economic, and social challenges that required urgent and coordinated action by countries and international organisations worldwide. The G20 countries, for instance, supported initiatives for equitable vaccine access, strengthened their respective healthcare systems, and promoted pandemic preparedness on a global scale. Not all the G20 economies are equal, however, and there were disparities in their COVID-19 responses and the outcomes. Indeed, the challenges they faced during the pandemic were unique, to begin with, given the differences in the structures and workings of their healthcare systems. In this post-COVID-19 era characterised by greater awareness that health security is of paramount importance to the overall security of nations, it is imperative to evaluate, through a comprehensive lens, the efficiency and effectiveness of healthcare systems.

Massive experimental, computational, and clinical studies have been performed worldwide, and are still ongoing, to understand and characterize Covid-19 molecular basis and transmission mechanisms, to develop diagnostics and vaccines, and to search for small chemical drug candidates and therapeutic proteins and peptides. Impressive results have been obtained for transmission control and vaccines so far, but what is the status of the other therapeutic options? The crisis has exposed different types of weaknesses in biomedical research in many countries. What can we learn from this crisis in the field of drug discovery and development so as to emerge stronger? The Covid-19 crisis has revealed the strengths of modern drug discovery and vaccine development but also exposed different types of weaknesses that would need to be addressed to be better prepared for a possible next global health crisis. These challenges/weaknesses/obstacles are of very different nature and as such hard to tackle. For instance, in addition to the inherent challenging nature of the scientific discovery, some scientists have mentioned insufficient local/national coordination and observed a fragmented drug discovery research, others have underlined a lack of coordination between the academic system and the private sector, an inadequate international global coordination and cooperation, others highlighted insufficient infrastructures, inappropriate financial supports, limited discussions between the scientific community performing the research and the public health authorities, decision makers and the society, while some remarked insufficient education/training about drug discovery and development leading to confusion… The crisis also raised important scientific questions about the technologies that would need to be used during an emergency situation, combined, integrated, or developed so as to accelerate the identification of small molecule drug candidates and of therapeutic peptides/proteins.

Online instruction is rapidly expanding the way administrators and educators think about and plan instruction. In addition, due to a pandemic, online instructional practices and learning in a virtual environment are being implemented with very little training or support. Educators are learning new tools and strategies at a quick pace, and often on their own, even through resistance. It is important to explore lessons learned through the pandemic but also of importance is sharing the virtual classroom options and instruction that align to best practices when transitioning to online instruction. Sharing these will allow educators to understand and learn that virtual instruction can benefit all, even when not used out of need, and can enhance face-to-face courses in many ways. The Handbook of Research on Lessons Learned From Transitioning to Virtual Classrooms During a Pandemic is a critical reference that presents lessons instructors have learned throughout the COVID-19 pandemic including what programs and tools were found to be the most impactful and useful and how to effectively embed virtual teaching into face-to-face teaching. With difficult choices to be made and implemented, this topic and collection of writings demonstrates the learning curve in a state of survival and also lessons and resources learned that will be useful when moving back to face-to-face instruction as a tool to continue to use. Highlighted topics include the frustrations faced during the transition, lessons learned from a variety of viewpoints, resources found and used to support instruction, online learner perspectives and thoughts, online course content, and best practices in transitioning to online instruction. This book is ideal for teachers, principals, school leaders, instructional designers, curriculum developers, higher education professors, pre-service teachers, in-service teachers, practitioners, researchers, and anyone interested in developing more effective virtual and in-classroom teaching methods.

In this issue of Nursing Clinics of North America, guest editor and Director of the COVID-19 Operations Control Center at Penn State College of Nursing Dr. Kelly A. Wolgast brings her considerable expertise to the topic of COVID-19 and Pandemic Preparedness: Lessons Learned and Next Steps Nurses have had to adapt and innovate in the clinical, leadership, technology, research, and academic environments to withstand the impacts of COVID-19, all while innovating new strategies to ensure that quality patient care remains the priority. This issue reflects the work and outcomes that stemmed from necessity by nurses and other health care partners to respond to the needs of patients during this extraordinary and challenging time in history. - Contains 14 practice-oriented topics including reaching the public with vaccination; long-term care and pandemic lessons learned; diversity impacts of COVID-19; clinical nursing during a pandemic: lessons learned; technology in the clinical setting for nurses: what worked and didn't work in the pandemic; and more. - Provides in-depth clinical reviews on COVID-19 and pandemic preparedness, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

At the beginning of 2020, as the COVID-19 pandemic swept across the US in multiple waves, health systems had to rapidly develop systems for tracking various aspects related to managing the pandemic. This included not just overall trends in incidence, hospitalizations, and outcomes; but also metrics related to the response. COVID-19 was the first pandemic in the United States since the widespread adoption of electronic health records incentivized by the Meaningful Use program. As a result, the availability of health information was much broader than in any previous pandemic. The widespread impact of COVID-19 also meant that every healthcare institution was affected, and was tracking data related to the pandemic in some form. There has been more focused activity with data and analytics regarding COVID-19 than we have ever had with any other disease, including important advances as well as technical and regulatory obstacles.

In this issue of Clinics in Chest Medicine, guest editors Drs. Drew Harris, Emily Brigham, and Juan Celedon bring their considerable expertise to the topic of Aiming to Improve Equity in Pulmonary Health. Top experts discuss disparities in risk factors for respiratory diseases, how communities are affected unequally, interventions to mitigate disparities, and evidence of effects, if present. - Contains 17 practice-oriented topics including racism and bias, tobacco use, air pollution and climate change, occupational hazards, access to care and rural health, asthma and COPD, lung cancer, pulmonary hypertension, migrants and refugees, sex and gender, homelessness and incarceration, mental illness, and more. - Provides in-depth clinical reviews of improving equity in pulmonary health, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.